- Home
- DTST vs CRIS Comparison
DTST vs CRIS Comparison
Compare DTST & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- CRIS
- Stock Information
- Founded
- DTST 2001
- CRIS 2000
- Country
- DTST United States
- CRIS United States
- Employees
- DTST N/A
- CRIS N/A
- Industry
- DTST EDP Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DTST Technology
- CRIS Health Care
- Exchange
- DTST Nasdaq
- CRIS Nasdaq
- Market Cap
- DTST 28.2M
- CRIS 21.3M
- IPO Year
- DTST N/A
- CRIS 2000
- Fundamental
- Price
- DTST $3.46
- CRIS $2.32
- Analyst Decision
- DTST
- CRIS Strong Buy
- Analyst Count
- DTST 0
- CRIS 2
- Target Price
- DTST N/A
- CRIS $16.50
- AVG Volume (30 Days)
- DTST 35.0K
- CRIS 71.8K
- Earning Date
- DTST 08-13-2025
- CRIS 07-31-2025
- Dividend Yield
- DTST N/A
- CRIS N/A
- EPS Growth
- DTST N/A
- CRIS N/A
- EPS
- DTST 0.02
- CRIS N/A
- Revenue
- DTST $25,219,312.00
- CRIS $11,202,000.00
- Revenue This Year
- DTST $12.57
- CRIS N/A
- Revenue Next Year
- DTST $9.29
- CRIS $10.67
- P/E Ratio
- DTST $145.21
- CRIS N/A
- Revenue Growth
- DTST N/A
- CRIS 14.17
- 52 Week Low
- DTST $2.93
- CRIS $1.02
- 52 Week High
- DTST $6.95
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- DTST 41.10
- CRIS 52.52
- Support Level
- DTST $3.34
- CRIS $2.11
- Resistance Level
- DTST $3.48
- CRIS $2.26
- Average True Range (ATR)
- DTST 0.18
- CRIS 0.21
- MACD
- DTST -0.03
- CRIS -0.04
- Stochastic Oscillator
- DTST 21.92
- CRIS 21.36
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.